Powder: -20°C for 3 years | In solvent: -80°C for 1 year
D-DOPA is an enantiomer of the dopamine precursor L-DOPA . It can be converted to L-DOPAviasequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.1It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.2Intraventricular administration of D-DOPA (200 μg/animal) increases striatal dopamine levels in rats.3D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson's disease induced by 6-OHDA .4
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
50 mg | 約 35 days | ¥ 33,000 |
100 mg | 約 35 days | ¥ 61,500 |
250 mg | 約 35 days | ¥ 126,500 |
500 mg | 約 35 days | ¥ 204,500 |
説明 | D-DOPA is an enantiomer of the dopamine precursor L-DOPA . It can be converted to L-DOPAviasequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.1It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.2Intraventricular administration of D-DOPA (200 μg/animal) increases striatal dopamine levels in rats.3D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson's disease induced by 6-OHDA .4 |
分子量 | 197.19 |
分子式 | C9H11NO4 |
CAS No. | 5796-17-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
0.1 M HCl: 10 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
D-DOPA 5796-17-8 DDOPA D DOPA Inhibitor inhibitor inhibit